康恩贝：吸入用复方异丙托溴铵溶液获得药品注册证书

Core Viewpoint - Kang En Bei's wholly-owned subsidiary, Jinhua Kang En Bei, has received approval from the National Medical Products Administration for the inhaled compound ipratropium bromide solution, which is intended for patients requiring multiple bronchodilators [2] Company Summary - The approved drug is designed for patients who need a combination of various bronchodilators [2]